Knowledge is power.
The Kellis IP Weekly
Since living in Brazil from 2021-2024 as the USPTO’s Intellectual Property Attaché for Brazil, Argentina, Paraguay, Uruguay, Guyana, and Suriname, Mr. Kellis has published the Kellis IP Weekly to help interested parties stay informed regarding intellectual property developments in Brazil and the surrounding region. If you have questions or concerns about any of the developments described in the Kellis IP Weekly and how those developments might impact your business, please contact Kellis IP.
Search the Kellis IP Weekly
The Kellis IP Weekly: Issue 11.1
G20 Health Ministers Agree on Creation of Vaccine Coalition: The coalition, to be headquartered in Brazil for the first 2 years before rotating to member countries, will rely on voluntary cooperation to improve access to vaccines, medicines, and diagnostics for orphan diseases and vulnerable populations. A key purpose of the coalition is to . . .
Click below to read more and see additional headlines.
The Kellis IP Weekly: Issue 10.5
INPI Releases Study on Patenting Scenario Surrounding Monoclonal Antibodies for Breast Cancer Treatment: The study, coordinated by INPI and conducted by the Technical Group for Intelligence in Industrial Property under the Interministerial Group for Intellectual Property (GIPI), evaluates patent applications related to the monoclonal antibodies trastuzumab and pertuzumab (which are costly for Brazil’s universal health system, SUS, to acquire) . . .
Click below to read more and see additional headlines.
The Kellis IP Weekly: Issue 10.4
Courts Prevent Retroactive Application of New Patent Appeal Guidelines: Decisions from the 9th, 12th, and 25th Federal Courts of Rio de Janeiro have all concluded that INPI’s new patent appeal guidelines, which went into force on April 2, cannot be applied retroactively. In the 9th Federal Court decision . . .
Click below to read more and see additional headlines.